Results 141 to 150 of about 3,852 (158)
Some of the next articles are maybe not open access.

The Integrated i31-GEP Test Outperforms the MSKCC Nomogram at Predicting SLN Status in Melanoma Patients

Anticancer Research, 2023
Sentinel lymph node biopsy (SLNB) for patients with cutaneous melanoma is primarily a prognostic procedure that broadly identifies patients who may have disease progression and may warrant additional intervention. However, 88% of patients undergoing SLNB receive a negative result and of those, some will succumb to their disease. One clinical utility of
Brian Martin
exaly   +3 more sources

I31 Enroll-HD: current status

Journal of Neurology, Neurosurgery & Psychiatry, 2016
Background Enroll-HD is a global observational registry study of Huntington’s disease (HD) designed to serve as a platform for clinical research. The first participant was recruited in 2012, and within less than 4 years, the study has in excess of 10 000 participants.
Olivia Handley   +5 more
openaire   +1 more source

LB1707 Cost implications of i31-GEP as a stratification tool for sentinel node positivity in cutaneous melanoma

Journal of Investigative Dermatology, 2023
E. Ma   +4 more
openaire   +1 more source

ISIDLB1707 - Cost implications of i31-GEP as a stratification tool for sentinel node positivity in cutaneous melanoma

2023
Michael Marchetti   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy